(Top left: Dr. Gang Zheng, bottom right: Dr. John Bell, right: Dr. Aly Karsan).
The Terry Fox Research Institute has invested nearly $21.5-million to renew three 2017 Terry Fox New Frontiers Program Project Grants (PPGs). The projects, based at three leading cancer institutes across Canada, will investigate acute leukemia, oncolytic viruses, and nanoparticle imaging in cancer interventions respectively over the next five years.
The successful teams are:
The Terry Fox New Frontiers Program Project Grant in [Canadian Oncolytic Virus Consortium: COVCo]; Principal Investigator: Dr. John Bell, Ottawa Hospital Research Institute;
The Terry Fox New Frontiers Program Project Grant in Exploiting Pathogenic Mechanisms in Acute Leukemia for Clinical Translation; Principal Investigator: Dr.
Aly Karsan, BC Cancer Agency;
The Terry Fox New Frontiers Program Project Grant in Porphysome Nanoparticle-Enabled Image-Guided Cancer Interventions; Principal Investigator: Dr. Gang Zheng, Princess Margaret Cancer Centre.
PPG awards are designed to bring together leading researchers with complementary skills to investigate different aspects of a given area of cancer research. By bringing individual research projects together under one PPG, results can be realized more rapidly and more efficiently. The 2017 Terry Fox New Frontiers Program Project Grants award winners will be profiled in greater detail shortly.